Literature DB >> 34888474

'Fast-track' pathway for resectable pancreatic cancer: barriers and facilitators to implementation across a regional network.

Basil Yannoulias1, Mark Exworthy1, Keith J Roberts2.   

Abstract

INTRODUCTION: The National Institute for Health and Care Excellence guidelines recommend a 'fast-track' approach to avoid preoperative biliary drainage (PBD) when treating resectable pancreatic cancer. For reasons not yet known, there is variable uptake of this approach across the UK. A 'fast-track' pathway which avoids PBD was introduced in University Hospitals Birmingham NHS Foundation Trust (UHB) and referring centres in 2015.
METHODOLOGY: Eleven semi-structured interviews were conducted with members of the hepatobiliary multidisciplinary team (MDT) in UHB and referring centres. Barriers and facilitators to pathway implementation were assessed.
RESULTS: Facilitators underpinning implementation were collaboration between stakeholders, clinical leadership and careful coordination of referrals. Barriers to implementation included clinician opposition and increased workload. Barriers were mitigated through phased implementation and the appointment of dedicated staff.
CONCLUSION: Future work may focus on exploring contextual factors in other tertiary centres and evaluating the emotional impact of 'fast-tracked' versus delayed surgery in patients with resectable pancreatic cancer. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  care pathways; fast-track surgery; pancreatic cancer

Year:  2021        PMID: 34888474      PMCID: PMC8651305          DOI: 10.7861/fhj.2021-0042

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  12 in total

Review 1.  Systematic methodological review: developing a framework for a qualitative semi-structured interview guide.

Authors:  Hanna Kallio; Anna-Maija Pietilä; Martin Johnson; Mari Kangasniemi
Journal:  J Adv Nurs       Date:  2016-06-23       Impact factor: 3.187

2.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

3.  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Authors:  John P Neoptolemos; Daniel H Palmer; Paula Ghaneh; Eftychia E Psarelli; Juan W Valle; Christopher M Halloran; Olusola Faluyi; Derek A O'Reilly; David Cunningham; Jonathan Wadsley; Suzanne Darby; Tim Meyer; Roopinder Gillmore; Alan Anthoney; Pehr Lind; Bengt Glimelius; Stephen Falk; Jakob R Izbicki; Gary William Middleton; Sebastian Cummins; Paul J Ross; Harpreet Wasan; Alec McDonald; Tom Crosby; Yuk Ting Ma; Kinnari Patel; David Sherriff; Rubin Soomal; David Borg; Sharmila Sothi; Pascal Hammel; Thilo Hackert; Richard Jackson; Markus W Büchler
Journal:  Lancet       Date:  2017-01-25       Impact factor: 79.321

4.  A reduced time to surgery within a 'fast track' pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy.

Authors:  Keith J Roberts; Pooja Prasad; Yvonne Steele; Francesca Marcon; Thomas Faulkner; Hentie Cilliers; Bobby Dasari; Manuel Abradelo; Ravi Marudanayagam; Robert P Sutcliffe; Paolo Muiesan; Darius F Mirza; John Isaac
Journal:  HPB (Oxford)       Date:  2017-05-26       Impact factor: 3.647

5.  Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer.

Authors:  S Sanjeevi; T Ivanics; L Lundell; N Kartalis; Å Andrén-Sandberg; J Blomberg; M Del Chiaro; C Ansorge
Journal:  Br J Surg       Date:  2015-11-17       Impact factor: 6.939

6.  Preoperative biliary drainage for cancer of the head of the pancreas.

Authors:  Niels A van der Gaag; Erik A J Rauws; Casper H J van Eijck; Marco J Bruno; Erwin van der Harst; Frank J G M Kubben; Josephus J G M Gerritsen; Jan Willem Greve; Michael F Gerhards; Ignace H J T de Hingh; Jean H Klinkenbijl; Chung Y Nio; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Patrick M M Bossuyt; Dirk J Gouma
Journal:  N Engl J Med       Date:  2010-01-14       Impact factor: 91.245

Review 7.  Large-system transformation in health care: a realist review.

Authors:  Allan Best; Trisha Greenhalgh; Steven Lewis; Jessie E Saul; Simon Carroll; Jennifer Bitz
Journal:  Milbank Q       Date:  2012-09       Impact factor: 4.911

8.  Receipt of Curative Resection or Palliative Care for Hepatopancreaticobiliary Tumours (RICOCHET): Protocol for a Nationwide Collaborative Observational Study.

Authors: 
Journal:  JMIR Res Protoc       Date:  2019-07-08

9.  Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer.

Authors:  R Pandé; J Hodson; A Murray; F Marcon; M Kalisvaart; R Marudanayagam; R P Sutcliffe; D F Mirza; J Isaac; K J Roberts
Journal:  BJS Open       Date:  2019-04-02

Review 10.  Neoadjuvant Treatment in Pancreatic Cancer.

Authors:  Atsushi Oba; Felix Ho; Quoc Riccardo Bao; Mohammed H Al-Musawi; Richard D Schulick; Marco Del Chiaro
Journal:  Front Oncol       Date:  2020-02-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.